Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Fund Letter | Christian RytherCurreen Capital | Enhabit, Inc. $EHAB• NASDAQ | Health Care Providers & ServicesHealth Care Providers & Services | Long EHAB (Enhabit) Similarly, we added to Enhabit when its price got attractive, despite the signs of improvement in that business. Enhabit provides healthcare... | BULL | View Pitch → |
| Aug 21, 2026 | Fund Letter | Christian RytherCurreen Capital | Enhabit, Inc. $EHAB• NASDAQ | Health Care Providers & ServicesHealth Care Providers & Services | Long EHAB (Enhabit, Inc.) Enhabit (2% at $7.68/share) ... We added to... | BULL | View Pitch → |
| Dec 4, 2025 | Fund Letter | Enhabit, Inc. $EHAB• NASDAQ | Health Care Providers & ServicesHealth Care Providers & Services | Clark Street Value 2025 Q2 (EHAB) Enhabit (EHAB) is a home health and hospice operator that was spun-off of Encompass Health (EHC), following the spinoff the company stubbed its toe badly (as is typical for many spins) as it was behind the industry shift from Medicare to Medicare Advantage plans. Much of that... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.